RESI Boston Early Bird Special Ends Tomorrow: Seeking Fundraising CEOs for RESI Innovation Challenge (View Past Winners Here)

21 Jul

With RESI Boston coming up soon, LSN’s scientific team is preparing to review the RESI Innovation Challenge applications from biotech, medtech and healthcare IT companies.  We’re excited to receive applications from companies at the cutting edge of biomedical science.  On September 13th, all RESI attendees will have the opportunity to vote on the 30 Innovation Challenge finalists.  See below for the past winners – a diverse group of startups from every area of the life sciences.

Every 90 days, RESI gathers hundreds of active early stage life science investors for a one-day partnering event. RESI Innovation Challenge finalists are provided with an all day showcase to attract the attention of those investors using their branding and messaging. It’s a unique opportunity to be a featured company in the life sciences industry. All applicants are vetted by LSN’s scientific review team, with a view to not just the quality of the company’s scientific work, but also the strength of the management team and how well-positioned the company is to receive investment.

What makes the RESI Innovation Challenge so valuable?  We’ve included a few words from previously successful participants below, but in short, being part of the Innovation Challenge provides startups with a new way to get attention and start dialogues with the investors who attend RESI.  Participants can share their message all day in the exhibit hall, with their Innovation Challenge display providing a starting point for a meaningful conversation about the opportunity.

Here is what our previous winners are saying about the RESI Innovation Challenge:

DSC00392

“It was an absolute pleasure to participate in the RESI conference held at MaRS in Toronto. The unique structure of the conference facilitated creating new relationships with potential investors and partners. In particular, the Innovation Challenge pushed us to introduce ourselves to new people, which will be useful as we look towards a future financing round. I definitely recommend the RESI conferences to entrepreneurs seeking financing in the bio / health space.”
 
– Raymond Shih, President, Co-Founder, QoC Health
3rd Place, RESI on MaRS, June 23, 2016

“I love the RESI Innovation Challenge because it is a great way to give our pitch to practice it and try to obtain a scarce resource from these investors. Practicing with these investors is a great way to build relationships and continue that on to the real investment conversations.”

– Niko Skievaski, Co-Founder, Redox

1st Place, RESI@TMCx, June 8, 2015

02

“The RESI Innovation Challenge is a really good opportunity to meet investors and other companies in the space.  It’s a good showcase to reach that audience.”

– Jessica Ching, CEO, Eve Medical

2nd Place, RESI San Francisco, January 12, 2016

“The RESI Innovation Challenge is a unique way to pitch, and provides a great opportunity to see what other companies are doing in the industry, while allowing you to meet with potential investors and strategic partners outside of the partnering meetings.”

– John Connolly, VP Corporate Development, Rna Diagnostics

1st Place, RESI Boston, September 16, 2015

01

“RESI offers small companies like GeneSegues a direct line to potential partners and potential investors in a small setting conducive to relationship building and conversation. The Innovation Challenge was a particularly great way to introduce our company to a broader audience than I could meet with personally which allowed us to leverage the showcasing of our technology more efficiently.”

-Laura M. Brod,Chief Executive Officer,GeneSegues Therapeutics

-1st Place, RESI @TMCx, April 11, 2016

RESI on MaRS June 23, 2016

1st Place
Paul Weber, President & CEO, Perimeter Medical Imaging
2nd Place
Geoff Fernie, CEO & CTO, Bresotec Inc
3rd Place (Tie)
Chancellor Crawford, Co-Founder & CEO, QoC Health
Ilana Odess, CEO, Woven Orthopedic Technologies

RESI@TMCx April 11, 2016

1st Place
Laura Brod, CEO, GeneSegues
2nd Place
Austin Dirks, CEO & CO-Founder, GreenLight Medical
3rd Place
Alexander Schüller, President, Adhesys

RESI San Francisco January 12, 2016

1st Place
 Shravanthi Reddy, COO, ClearSight
2nd Place
Jessica Ching, CEO, Eve Medical
3rd Place
Jonathan W. Gunn, JD, PhD, CEO & Co-founder

RESI Boston September 16, 2015

1st Place
Jonathan W. Gunn, JD, PhD, CEO & Co-founder, Rna Diagnostics
2nd Place
Matthew R. Gevaert, Ph.D. CEO & Co-founder
3rd Place
Kenneth J. Slepicka, CEO & Director

RESI@TMCx June 8, 2015

1st Place
Niko Skievaski, Co-founder, Redox
2nd Place
Wade Lange, CEO, NeuroFx
3rd Place
Laura Bosworth, CEO & co-founder, TeVido BioDevices

RESI San Francisco January 13, 2015

1st Place
Shawn Iadonato, Ph.D., CEO, Kineta
2nd Place
Eric Goslau, CEO, Transverse Medical
3rd Place
Robert Thompson, President & CEO, Amorphex Therapeutics

RESI Boston September 17, 2014

1st Place
Robin Smith, CEO, ORIG3N
2nd Place
Jeff Missling, CEO, SpineThera
3rd Place
Kurt Dieck, President & CEO, Biosortia

RESI Boston March 24, 2014

1st Place
Pam Randhawa, Founder & CEO, EMPIRIKO
2nd Place
Marcia Fournier, CEO, BIOARRAY
3rd Place (Tie)
Magdalena Leszczyniecka, President & CEO, STC Biologics
Tasos Smeros, Founder & CEO, Multineurons

Apply today for the chance to join!

button

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: